Never miss a story

Get subscribed to our newsletter


×
Contraceptives, Wikimedia commons

New types of combined birth control pills — containing both lower doses of oestrogens and newer progestogens — may reduce the risk of ovarian cancer among young women, says a study.

The study, published in the journal The BMJ, showed that this positive effect strengthened with longer periods of use and persisted for several years after stopping.


“The reduced risk seems to persist after stopping use, although the duration of benefit is uncertain,” the study said.

At least 100 million women worldwide use hormonal contraception every day.


The study found that genes on the X-chromosome get potentially passed down through the father to his daughter, thus increasing the risk of ovarian cancer in girls. Wikimedia Commons

For the study, the researchers from University of Aberdeen in Scotland and the University of Copenhagen in Denmark analysed data for nearly 1.9 million Danish women aged 15-49 years between 1995 and 2014.

Women were categorised as never users (no record of being dispensed hormonal contraception), current or recent users (up to one year after stopping use), or former users (more than one year after stopping use) of different hormonal contraceptives.

Most (86 per cent) of the hormonal contraceptive use related to combined oral products.

The researchers found that the number of cases of ovarian cancer were highest in women who had never used hormonal contraception (7.5 per 100,000 person years), whereas among women who had ever used hormonal contraception, the number of cases of ovarian cancer were 3.2 per 100,000 person years.


At least 100 million women worldwide use hormonal contraception every day. . (IANS)

The reduced risk for combined products was seen with nearly all types of ovarian cancer, and there was little evidence of important differences between products containing different types of progestogens.

“Based on our results, contemporary combined hormonal contraceptives are still associated with a reduced risk of ovarian cancer in women of reproductive age, with patterns similar to those seen with older combined oral products,” the study authors said.

Also Read: High Immunity Protein At Birth Cuts Childhood Malaria Risk

Previous research had shown that the older products, containing higher levels of oestrogen and older progestogens, were tied to reduced ovarian cancer risk.

But it was not known whether the newer contraceptives carried the same benefit. (IANS)


Popular

Unsplash

Robots evolve to do more work around us

As robots evolve to do more work around us, the UK-based humanoid robot manufacturer Engineered Arts has infused more human-like facial expressions into one of its robots, which may leave you with an eerie feeling.

In a video posted on YouTube, the robot called 'Ameca' displays various human expressions, like appearing to "wake up" from sleep, as its face shows confusion and frustration when it opens its eyes.

Follow NewsGram on Twitter to stay updated about the World news.

Keep Reading Show less
Unsplash

The Microsoft office

Microsoft has disrupted the activities of a China-based hacking group, gaining control of the malicious websites the group used to attack organisations in the US and 28 other countries around the world.

The Microsoft Digital Crimes Unit (DCU) said in a statement that a federal court in Virginia granted its request to seize websites of the hacking group called 'Nickel', enabling the company to cut off Nickel's access to its victims and prevent the websites from being used to execute attacks.

Keep Reading Show less
Unsplash

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity

Chip manufacturer MediaTek on Monday announced that it is focused on making 2022 a year aimed at rapid growth, business success, substantial expansion in Research and Development capabilities.

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity with its range of mainstream to flagship 5G chips.

"We at MediaTek are focused on making 2022 a year aimed at rapid growth, business success, and substantial expansion in our R&D capabilities. For 2022, we are focused on further strengthening our presence in India, offering incredible experiences to customers, and supporting the country's technology initiatives with our expertise and collaboration with leading OEMs," Anku Jain, Managing Director, MediaTek India said in a statement.

Follow NewsGram on LinkedIn to know what's happening around the world.

In the flagship segment, MediaTek recently announced the Dimensity 9000 chip, which is a milestone of innovation and a rise to the incredible, built-to-power flagship 5G smartphones in the world, the company claims.

MediaTek Dimensity 9000 features a single Cortex-X2 performance core clocked at 3.05GHz, three Cortex-A710 cores at 2.85GHz and four Cortex-A510 efficiency cores at 1.8GHz.

It packs a 10-core Arm Mali-G710 that takes care of graphics processing, the report said.

Keep reading... Show less